Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Leukemia × Razoxane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Cardiotoxicity 5 Sarcoma 3 Lymphoma 3 Sarcoma, Synovial 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroblastoma 1 Lymphoma, Large-Cell, Anaplastic 1 Localized Extraskeletal Ewing Sarcoma 1 Liposarcoma 1 Leukemia 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Fibrosarcoma 1 Extravasation 1 Dermatofibrosarcoma 1

Interventions

Cyclophosphamide 204 Cytarabine 173 fludarabine phosphate 116 Methotrexate 110 Filgrastim 110 Etoposide 92 Busulfan 86 Rituximab 75 fludarabine 68 Peripheral Blood Stem Cell Transplantation 68 Vincristine 66 Radiotherapy 66 Daunorubicin 60 Dexamethasone 54 Antilymphocyte Serum 53 Cyclosporine 51 Melphalan 49 Imatinib Mesylate 45 Tacrolimus 44 Mycophenolic Acid 41 Whole-Body Irradiation 40 Mercaptopurine 40 Idarubicin 39 Granulocyte Colony-Stimulating Factor 39 Methylprednisolone 36 Flow Cytometry 36 Doxorubicin 36 Clofarabine 36 Prednisone 34 Asparaginase 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01230983 2013-06-06

T-Cell #4

Children's Oncology Group

Phase 3 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡